Steffin DHM, Muhsen IN, Hill LC, et al. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022;140(1):16-24.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163306/
https://www.ncbi.nlm.nih.gov/pubmed/36929434
http://dx.doi.org/10.1182/blood.2022019334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163306/
https://www.ncbi.nlm.nih.gov/pubmed/36929434
http://dx.doi.org/10.1182/blood.2022019334

Ejemplares similares